Skip to main content
Premium Trial:

Request an Annual Quote

Orion Genomics to Use Genomics Collaborative s Tissue Samples for Cancer Biomarker Discovery

NEW YORK, May 4 (GenomeWeb News) - Genomics Collaborative, a division of SeraCare Life Sciences, said today that it will provide Orion Genomics with annotated clinical tumor tissue specimens for use in Orion's cancer biomarker discovery and validation program.

 

Orion Genomics, a developer of DNA-methylation-based molecular diagnostics, will screen the tissue samples to discover and validate epigenetic biomarkers that are indicative of the presence and stage of disease, Genomics Collaborative said.

 

The deal is the second procurement agreement between the two firms.

 

Additional terms were not disclosed.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.